87 related articles for article (PubMed ID: 7688913)
1. Utility of the murine erythroleukemic cell (MELC) in assessing mechanisms of action of DNA-active developmental toxicants: application to 5-fluorouracil.
Elstein KH; Zucker RM; Shuey DL; Lau C; Chernoff N; Rogers JM
Teratology; 1993 Jul; 48(1):75-87. PubMed ID: 7688913
[TBL] [Abstract][Full Text] [Related]
2. Biologically based dose-response modeling in developmental toxicology: biochemical and cellular sequelae of 5-fluorouracil exposure in the developing rat.
Shuey DL; Lau C; Logsdon TR; Zucker RM; Elstein KH; Narotsky MG; Setzer RW; Kavlock RJ; Rogers JM
Toxicol Appl Pharmacol; 1994 May; 126(1):129-44. PubMed ID: 8184423
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside-mediated mitigation of 5-fluorouracil-induced toxicity in synchronized murine erythroleukemic cells.
Elstein KH; Mole ML; Setzer RW; Zucker RM; Kavlock RJ; Rogers JM; Lau C
Toxicol Appl Pharmacol; 1997 Sep; 146(1):29-39. PubMed ID: 9299594
[TBL] [Abstract][Full Text] [Related]
4. Effects of developmental stage and tissue type on embryo/fetal DNA distributions and 5-fluorouracil-induced cell-cycle perturbations.
Elstein KH; Zucker RM; Andrews JE; Ebron-McCoy M; Shuey DL; Rogers JM
Teratology; 1993 Oct; 48(4):355-63. PubMed ID: 8278935
[TBL] [Abstract][Full Text] [Related]
5. Effects of 4-hydroperoxycyclophosphamide (4-OOH-CP) and 4-hydroperoxydechlorocyclophosphamide (4-OOH-deCICP) on the cell cycle of post implantation rat embryos.
Little SA; Mirkes PE
Teratology; 1992 Feb; 45(2):163-73. PubMed ID: 1615426
[TBL] [Abstract][Full Text] [Related]
6. Cell death and cell cycle perturbation in the developmental toxicity of the demethylating agent, 5-aza-2'-deoxycytidine.
Rogers JM; Francis BM; Sulik KK; Alles AJ; Massaro EJ; Zucker RM; Elstein KH; Rosen MB; Chernoff N
Teratology; 1994 Nov; 50(5):332-9. PubMed ID: 7536356
[TBL] [Abstract][Full Text] [Related]
7. Toward a biologically based dose-response model for developmental toxicity of 5-fluorouracil in the rat: acquisition of experimental data.
Lau C; Mole ML; Copeland MF; Rogers JM; Kavlock RJ; Shuey DL; Cameron AM; Ellis DH; Logsdon TR; Merriman J; Setzer RW
Toxicol Sci; 2001 Jan; 59(1):37-48. PubMed ID: 11134542
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.
McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ
Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143
[TBL] [Abstract][Full Text] [Related]
9. Changes in p34cdc2 kinase activity and cyclin A during induced differentiation of murine erythroleukemia cells.
Kiyokawa H; Ngo L; Kurosaki T; Rifkind RA; Marks PA
Cell Growth Differ; 1992 Jun; 3(6):377-83. PubMed ID: 1419901
[TBL] [Abstract][Full Text] [Related]
10. Biological modeling of 5-fluorouracil developmental toxicity.
Shuey DL; Setzer RW; Lau C; Zucker RM; Elstein KH; Narotsky MG; Kavlock RJ; Rogers JM
Toxicology; 1995 Sep; 102(1-2):207-13. PubMed ID: 7482555
[TBL] [Abstract][Full Text] [Related]
11. Effects of 5-fluorouracil on embryonic rat palate in vitro: fusion in the absence of proliferation.
Abbott BD; Lau C; Buckalew AR; Logsdon TR; Setzer W; Zucker RM; Elstein KH; Kavlock RJ
Teratology; 1993 Jun; 47(6):541-54. PubMed ID: 8367827
[TBL] [Abstract][Full Text] [Related]
12. Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil.
Yeh KH; Yeh SH; Hsu CH; Wang TM; Ma IF; Cheng AL
Br J Cancer; 2000 Dec; 83(11):1510-5. PubMed ID: 11076661
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide teratogenesis: evidence for compensatory responses to induced cellular toxicity.
Francis BM; Rogers JM; Sulik KK; Alles AJ; Elstein KH; Zucker RM; Massaro EJ; Rosen MB; Chernoff N
Teratology; 1990 Nov; 42(5):473-82. PubMed ID: 2278024
[TBL] [Abstract][Full Text] [Related]
14. Early events following maternal exposure to 5-fluorouracil lead to dysmorphology in cultured embryonic tissues.
Shuey DL; Buckalew AR; Wilke TS; Rogers JM; Abbott BD
Teratology; 1994 Dec; 50(6):379-86. PubMed ID: 7778042
[TBL] [Abstract][Full Text] [Related]
15. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
[TBL] [Abstract][Full Text] [Related]
16. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
Longley DB; Boyer J; Allen WL; Latif T; Ferguson PR; Maxwell PJ; McDermott U; Lynch M; Harkin DP; Johnston PG
Cancer Res; 2002 May; 62(9):2644-9. PubMed ID: 11980662
[TBL] [Abstract][Full Text] [Related]
17. Cell-cycle alterations underlie cyclophosphamide-induced teratogenesis in the chick embryo.
Heringová L; Jelínek R; Dostál M
Birth Defects Res A Clin Mol Teratol; 2003 Jun; 67(6):438-43. PubMed ID: 12962288
[TBL] [Abstract][Full Text] [Related]
18. Fetal anemia following maternal exposure to 5-fluorouracil in the rat.
Shuey DL; Zucker RM; Elstein KH; Rogers JM
Teratology; 1994 Apr; 49(4):311-9. PubMed ID: 8073370
[TBL] [Abstract][Full Text] [Related]
19. An efficient multiple-exposure analysis of the toxicity of crisnatol, a DNA intercalator in phase II clinical trials.
Zucker RM; Adams DJ; Bair KW; Elstein KH
Invest New Drugs; 1992 Apr; 10(1):1-15. PubMed ID: 1607248
[TBL] [Abstract][Full Text] [Related]
20. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
Ladner RD; Lynch FJ; Groshen S; Xiong YP; Sherrod A; Caradonna SJ; Stoehlmacher J; Lenz HJ
Cancer Res; 2000 Jul; 60(13):3493-503. PubMed ID: 10910061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
